Defining the impact of prognostic factors at the time of relapse for nonmetastatic rhabdomyosarcoma.
Maria Carmen AffinitaAndrea C FerrariStefano ChiaravalliFraia MelchiondaLucia QuagliettaMichela CasanovaIlaria ZanettiGiovanni ScarzelloLuisa Di PasqualeAndrea Di CataldoGianni BisognoPublished in: Pediatric blood & cancer (2020)
Our study demonstrates that to estimate the chance of cure in patients with relapsed RMS, we should also consider tumor characteristics at the time of relapse, and tumor size in particular.